Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2010
10/20/2010CN101157722B Cattle mycobacterium Mce4E protein, preparation method and uses thereof
10/19/2010US7816590 Plants and seeds of corn variety CV338423
10/19/2010US7816588 Inbred sweet corn line R373D
10/19/2010US7816583 Sweet grape tomato
10/19/2010US7816578 produces antibodies comprising two human immunoglobulin loci for use in the treatmnent of cardiovascular, infections, cancer and autoimmune disorders
10/19/2010US7816511 Screening drugs; prevent gene expression; monitoring cardiovascular disorders
10/19/2010US7816508 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses;
10/19/2010US7816506 Methods and constructs for producing transgenic plants and methods of recovering expressed proteins
10/19/2010US7816504 PUFA polyketide synthase systems and uses thereof
10/19/2010US7816501 Peptide nucleic acids with donor and acceptor moieties for detecting or identifying the presence, absence or quantity of a target sequence of a target molecule such as via fluorescence resonance energy transfer
10/19/2010US7816496 Carbonic anhydrase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
10/19/2010US7816495 Processes for the preparation of fibrinogen
10/19/2010US7816494 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides; wound healing agents
10/19/2010US7816493 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast
10/19/2010US7816492 Human G protein-coupled receptors
10/19/2010US7816491 Ordered biological nanostructures formed from chaperonin polypeptides
10/19/2010US7816490 Peptide for use in the treatment of immunological defects and allergies; capable of inhibiting protein-protein interaction between calcineurin and NFAT
10/19/2010US7816489 Methods for making intermediates and oxytocin analogues
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816321 treating skin lesions, heart injuries, corneal lesions and/or coronary heart disease
10/19/2010US7816320 point mutations with p-acetyl phenylalanine; covalently linked to poly(ethylene glycol); histidine buffer
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816132 DNA encoding plexin polypeptides and kits thereof
10/19/2010US7816131 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain
10/19/2010US7816109 Microorganism having the improved gene for hydrogen-generating capability, and process for producing hydrogen using the same
10/19/2010US7816104 Packaging cells for recombinant adenovirus
10/19/2010US7816103 Protein having amino acid sequence in SEQ ID No.: 1 of the Sequence Listing derived from human MP52, and a dimer protein homodimer protein described above can be obtained by constructing a plasmid containing DNA coding amino acid; for treating cartilage and bone diseases
10/19/2010US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents
10/19/2010US7816093 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
10/19/2010US7816091 Method of identifying a binding partner to a cytokine receptor common gamma chain like polypeptide
10/19/2010US7816087 Gene expressed in prostate cancer and methods of use
10/19/2010US7816086 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
10/19/2010US7816085 generating a polynucleotide sequence or population of sequences from parent single stranded polynucleotide sequences encoding one or more protein motifs; amplification
10/19/2010US7816076 Therapeutic targets in cancer
10/19/2010US7815918 Pneumococcal surface protein A for use in diagnosis, prevention and treatment of pneumocystis infection
10/19/2010US7815916 Using human T cell leukemia virus type III (HTLV-III) RNA to diagnose, treat and prevent infection by human aquired immunodeficiency virus; viricides
10/19/2010US7815915 Mixture of human papillomavirus virus-like particles
10/19/2010US7815912 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010US7815896 Type III secretion pathway in Aeromonas salmonicida and uses therefor
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/19/2010CA2430661C Purified active hcv ns2/3 protease
10/19/2010CA2429138C Sol-fusin: use of gp64-6his to catalyze membrane fusion
10/19/2010CA2420159C Model animal for type iii allergy inflammation
10/19/2010CA2400667C Modified nodavirus rna for gene delivery
10/19/2010CA2397527C Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
10/19/2010CA2385287C Signal sequences for preparing leu-hirudin by secretion by e. coli into the culture medium
10/19/2010CA2381489C G-csf analog compositions and methods
10/19/2010CA2376031C Product from starfish
10/19/2010CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
10/19/2010CA2325803C Novel omega conotoxin peptides
10/19/2010CA2298412C Identification of human cell lines for the production of human proteins by endogenous gene activation
10/19/2010CA2218251C Coding sequences of the human brca1 gene
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2177249C Abundant extracellular products and methods for their production and use
10/19/2010CA2174559C Antibody to aminoterminal propeptide of type 1 procollagen, and assay method using it
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/19/2010CA2147499C Prostate-specific membrane antigen
10/19/2010CA2103248C Novel bacillus thuringiensis isolates active against hymenopteran pests and genes encoding hymenopteran-active toxins
10/17/2010CA2701052A1 Method of cancer treatment
10/17/2010CA2662984A1 Activation of high protein corn gluten by ph modification
10/14/2010WO2010118347A2 O-linked glycan biosynthesis modulators
10/14/2010WO2010118169A2 Human protein scaffold with controlled serum pharmacokinetics
10/14/2010WO2010117978A1 Peptides for stimulating plant disease resistance
10/14/2010WO2010117786A1 Influenza virus vaccines and uses thereof
10/14/2010WO2010117785A1 Leptin antagonist and methods of use
10/14/2010WO2010117753A2 Peptide compositions for oral care systems
10/14/2010WO2010117750A2 Engineering broad-spectrum disease resistance against haustorium-forming pathogens using rpw8 as a delivery vehicle
10/14/2010WO2010117725A2 Production of peptides containing poly-gly sequences using fmoc chemistry
10/14/2010WO2010117694A2 Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis
10/14/2010WO2010117652A1 Differentially protected orthogonal lanthionine technology
10/14/2010WO2010117079A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010117078A1 Neuronal differentiation-inducing peptide and use thereof
10/14/2010WO2010116994A1 Method for producing porous silk fibroin material
10/14/2010WO2010116375A1 Isolated peptides for regulating apoptosis
10/14/2010WO2010116258A1 Neuron generation, regeneration and protection
10/14/2010WO2010116016A1 Use of peptides of the e1 protein of the hepatitis g virus in order to inhibit the activity of the hiv virus
10/14/2010WO2010115990A1 Filtration of a liquid comprising a plant stress protein
10/14/2010WO2010115989A1 Diagnostic mycobacterium tuberculosis test
10/14/2010WO2010115987A1 Transgenic mouse and cell models and their uses for identification of drugs targeting brain-derived neurotrophic factor
10/14/2010WO2010115916A1 Process for isolating therapeutic peptide
10/14/2010WO2010115866A1 Targeted delivery of factor viii proteins to platelets
10/14/2010WO2010115843A2 Pharmaceutical composition
10/14/2010WO2010115589A1 Trivalent, bispecific antibodies
10/14/2010WO2010115586A2 Method for purifying recombinant fsh
10/14/2010WO2010115551A1 Bispecific anti-erbb-1/anti-c-met antibodies
10/14/2010WO2010115368A1 Rice zinc finger protein transcription factor dst and use thereof for regulating drought and salt tolerance
10/14/2010WO2010115318A1 Follicle-stimulating hormone with high specific activity and preparation method thereof
10/14/2010WO2010115286A1 Dopamine d2 receptor-disc1 interaction, compositions and methods for modulating same
10/14/2010WO2010115278A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010WO2010115261A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010WO2010096562A3 Yeast cells expressing an exogenous cellulosome and methods of using the same
10/14/2010WO2010089671A3 Contiguous overlapping peptides for treatment of birch pollen allergy
10/14/2010WO2010078928A3 Specific and persistent activation of heat shock response in cell lines using a viral factor
10/14/2010WO2010071897A3 Engineering heat-stable disease resistance in plants
10/14/2010WO2010068686A3 Methods of diagnosing and predicting renal disease
10/14/2010WO2010068684A3 Methods and compositions for specific modulation of mcl-1
10/14/2010WO2010065863A3 Assays for identifying genes encoding salty taste receptors and modulators
10/14/2010WO2010065850A3 Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition
10/14/2010WO2010062975A3 Suppressor of ap-1
1 ... 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 ... 2916